Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in…
Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Shanghai Junshi Biosciences
US FDA declines to approve two more China-tested drugs
The decisions could add pressure on Chinese stocks, especially biotech companies, at a time shares of several US-listed Chinese…
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through…